Effect of anti-epileptic drugs in pregnancy and teratogenesis |
| |
| Authors: | Sowbhagya Lakshmi Kulkarni Sunanda |
| |
| Institution: | (1) Department of Biochemistry, Bangalore Medical College, Bangalore, 560 002, India;(2) Department of Obstetrics & Gynecology, Bangalore Medical College, Bangalore, 560 002, India;(3) Govt. Medical College, Shimoga, Karnataka, India |
| |
| Abstract: | Epilepsy raises special concern in women during pregnancy. Antiepileptic drugs are known to induce major and minor malformations
in the foetus. Aim of the study was to find an association between maternal serum alpha fetoprotein levels, foetal abnormalities
and antiepileptic drugs mediated teratogenicity. Maternal serum alpha feto protein levels, kidney and liver function tests
in age matched normal pregnant women and seizure free epileptic pregnant women during 12–14 weeks of gestation were estimated.
Cases were subjected to ultrasonography at 11th–14th week of pregnancy and again at 20th week of pregnancy. maternal serum alfa feto protein was assayed by a specific Electro Chemiluminescence Immuno Assay test.
There was no significant difference in kidney and liver function tests in cases as compared to controls. There were elevated
levels of alpha feto protein in cases as compared to controls but this was not statistically significant. No anomalies were
detected in ultrasound reports. Most women had normal full term delivery with healthy children but of low birth weight. No
correlation was seen between maternal serum alfa feto protein levels and antiepileptic drug leading to teratogenesis. |
| |
| Keywords: | Alpha feto proteins Antiepileptic drugs Teratogenic effects Chemiluminescence |
| 本文献已被 SpringerLink 等数据库收录！ |
|
